Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
/in International Publications, Malignant Lymphoma, Newcastle Disease Virus /von 2015-12-23 / Viruses 2015 Dec;8(1)Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
/in Breast Cancer, Hyperthermia, International Publications /von 2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-87Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
/in International Publications, Newcastle Disease Virus /von 2015-12-21 / J. Exp. Clin. Cancer Res. 2015 Dec;34:153Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-12-16 / Mol. Cancer 2015 Dec;14:210Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-18A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-76Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-12-08 / Genet. Mol. Res. 2015 Dec;14(4):16222-32Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells
/in Dendritic Cells, HIV/AIDS, International Publications /von 2015-12-08 / J. Infect. Dis. 2016 May;213(9):1400-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution